Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1283658-71-8
1415800-34-8
1621616-14-5
1807503-87-2
1807521-04-5
2055014-77-0
654651-21-5 | BDP 581/591 NHS ester | AA019EFH | MFCD31580123
40649-26-1 | N-Cyclopentylaniline | AA019EJ1 | MFCD09608069
41102-02-7 | 7-bromo-1H-thieno[3,2-d]pyrimidine-2,4-dione | AA019ELR | MFCD11869288
1285530-55-3 | N-(4-Bromopyridin-2-yl)propionamide | AA019EP7 | MFCD23131207
1161864-92-1 | 2-(Phenylsulfonyl)nicotinaldehyde | AA019ESB | MFCD29917041
172992-35-7 | (S)-3-(4-(Benzyloxy)Phenyl)-2-Butyramidopropanoic Acid | AA019EVU | MFCD30471758
630119-99-2 | 1-PIPERIDINECARBOXYLIC ACID, 4-HYDROXY-4-(2-THIENYL)-, 1,1-DIMETHYLETHYL ESTER | AA019EYP | MFCD30294433
5945-33-5 | Tetraphenyl (propane-2,2-diylbis(4,1-phenylene)) bis(phosphate) | AA019FSA | MFCD09753077
1227575-01-0 | 4-(bromomethyl)-2-chloro-6-(trifluoromethyl)pyridine | AA019GBP | MFCD16610143
379255-70-6 | 3-[(5-chloro-2,4-dimethoxyphenyl)(methyl)sulfamoyl]benzoic acid | AA019GJ8 | MFCD03147393